Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Date: August 8, 2017
Pages: 29
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C83F3301F2CEN
Leaflet:

Download PDF Leaflet

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review
Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Chiesi Farmaceutici SpA (Chiesi) researches, develops, produces and commercializes novel medicines with focus on respiratory, neonatology, rare disease and special care therapeutic areas. The company provides products for the treatment of chronic obstructive pulmonary disease (COPD), asthma, rheumatoid arthritis, ankylosing spondylitis, hypertension, percutaneous coronary intervention, apnoea of prematurity, respiratory distress syndrome (RDS), lipoprotein lipase deficiency (LPLD), limbal stem cell deficiency (LSCD), inflammatory bowel diseases and renal and liver failure - solid organ transplant (SOT). The company operates production sites in Parma, Italy; Blois, France; and Santana De Parnaiba, Brazil; and carries out research and development (R&D) activities at its new R&D center in Parma and at laboratories in Paris, Chippenham (UK), Cary (US), Lidingo (Sweden) and Hillerod (Denmark). Chiesi is headquartered in Parma, Italy.

Chiesi Farmaceutici SpA Key Recent Developments

Nov 06,2016: GOLD 2017 Report: Chiesi Farmaceutici highlights relevant gaps
Sep 03,2016: The Lancet Publishes The Results Of Chiesi Farmaceutici Trilogy Study
May 03,2016: Kamada Receives Two Milestone Payments under Strategic Agreements with Chiesi Farmaceutici and Baxalta
Mar 30,2016: 80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Chiesi Farmaceutici SpA - Key Facts
Chiesi Farmaceutici SpA - Key Employees
Chiesi Farmaceutici SpA - Major Products and Services
Chiesi Farmaceutici SpA - History
Chiesi Farmaceutici SpA - Company Statement
Chiesi Farmaceutici SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Chiesi Farmaceutici SpA - Business Description
Chiesi Farmaceutici SpA - Corporate Strategy
Chiesi Farmaceutici SpA - SWOT Analysis
SWOT Analysis - Overview
Chiesi Farmaceutici SpA - Strengths
Chiesi Farmaceutici SpA - Weaknesses
Chiesi Farmaceutici SpA - Opportunities
Chiesi Farmaceutici SpA - Threats
Chiesi Farmaceutici SpA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Chiesi Farmaceutici SpA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Sep 03, 2016: The Lancet Publishes The Results Of Chiesi Farmaceutici Trilogy Study
May 03, 2016: Kamada Receives Two Milestone Payments under Strategic Agreements with Chiesi Farmaceutici and Baxalta
Mar 30, 2016: 80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Chiesi Farmaceutici SpA, Key Facts
Chiesi Farmaceutici SpA, Key Employees
Chiesi Farmaceutici SpA, Major Products and Services
Chiesi Farmaceutici SpA, History
Chiesi Farmaceutici SpA, Subsidiaries
Chiesi Farmaceutici SpA, Key Competitors
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Chiesi Farmaceutici SpA, Recent Deals Summary

LIST OF FIGURES

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Zambon Italia Srl
SIFI SpA
Siena Biotech SpA
Newron Pharmaceuticals SpA
FB Health SpA
Cosmo Pharmaceuticals NV
Skip to top


Sorgenia SpA - Strategic SWOT Analysis Review US$ 125.00 Nov, 2015 · 28 pages
Sonatrach SPA - Strategic SWOT Analysis Review US$ 125.00 Mar, 2017 · 40 pages
Sonelgaz Spa - Strategic SWOT Analysis Review US$ 125.00 Mar, 2014 · 19 pages
Polynt SpA - Strategic SWOT Analysis Review US$ 125.00 Sep, 2016 · 21 pages

Ask Your Question

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: